Riskpilot← Back to searchSign inGet full accessBernhoft Global Invest ApS
APSActiveCVR 43340573Sandbjergvej 12Activities of holding companies · NACE 6421Est. 20227 employees
Revenue 2024
DKK -2M
-96% vs 2023
EBITDA margin
421.1%
+85% vs 2023
Equity ratio
98.4%
Financial strength
Net profit 2024
DKK 22,3M
+223% vs 2023
| Revenue | DKK -2M | -96% |
| EBITDA | DKK -8,6M | +85% |
| Net profit | DKK 22,3M | +223% |
| Total assets | DKK 963,8M | +4% |
| Equity | DKK 948M | +2% |
| Employees | 7 | — |
Legal name
Bernhoft Global Invest ApS
CVR number
43340573
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
31. maj 2022
Share capital
DKK 100.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af selskabets administrerende direktør eller af bestyrelsesformanden eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at forestå investeringer i erhvervsdrivende selskabet i Danmark og i udlandet samt anden i forbindelse hermed stående virksomhed.
Address
Sandbjergvej 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | -5.686 | -49.531 | -2.040 |
| Staff expenses | -3.530 | -6.445 | -6.550 |
| EBITDA | -9.216 | -55.976 | -8.590 |
| Depreciation & amort. | -15 | -28 | -34 |
| EBIT | -9.231 | -56.004 | -8.624 |
| Net financials | -3.412 | 40.915 | 47.155 |
| Profit before tax | -12.643 | -15.089 | 38.531 |
| Tax | -0 | 3.108 | 16.192 |
| Net profit | -12.643 | -18.197 | 22.339 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 944.235 | 926.433 | 963.819 |
| Equity | 943.849 | 925.650 | 947.987 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 386 | 783 | 15.832 |
| Total debt | 386 | 783 | 15.832 |
EBITDA margin
-859000000.0%
This company
15.8%
Market median
-5436708961% vs market
20222024
Equity ratio
98.4%
This company
38.2%
Market median
+158% vs market
20222024
Return on equity
2.4%
This company
18.4%
Market median
-87% vs market
20222024
Net profit margin
2233900000.0%
This company
8.1%
Market median
+27579012246% vs market
20222024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20222024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SH Management | Management | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 66.7% | 66.7% | 2024 | |
BERNHOFT P.E.I. ApS | Company | 10.0% | 10.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bernhoft Global Invest ApS (this company)
Apex Health ApSBoard members of Bernhoft Global Invest ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Hendrik Leissler | Management | 0 companies |
| John Korsø Jensen | Chairman | 0 companies |
| Michael Serup | Board of Directors | 0 companies |